JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.96B |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.61B |
| 4 |
UnitedHealth
UNH
|
+$1.1B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.25B |
| 2 |
Centene
CNC
|
+$827M |
| 3 |
Amazon
AMZN
|
+$791M |
| 4 |
Texas Instruments
TXN
|
+$716M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$569M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.62% |
| 2 | Healthcare | 12.48% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNS
4126
DELISTED
Sapiens International
SPNS
| $596K | ﹤0.01% |
31,118
+14,674
| +89% | +$332K |
|
4127
BlackBerry
BB
$5.22B
| $595K | ﹤0.01% |
126,616
-446
| -0.4% | -$2.67K |
|
4128
Claros Mortgage Trust
CMTG
$257M
| $595K | ﹤0.01% |
50,682
+1,494
| +3% | +$25.6K |
|
4129
Endava
DAVA
$164M
| $594K | ﹤0.01% |
7,360
-5,875
| -44% | -$558K |
|
4130
PUT
Cardinal Health
CAH
$54.7B
| $593K | ﹤0.01% |
8,900
| – | – |
|
4131
Solid Power
SLDP
$552M
| $592K | ﹤0.01% |
112,567
+39,643
| +54% | +$250K |
|
4132
CALL
Hilton Worldwide
HLT
$73.6B
| $591K | ﹤0.01% |
4,900
-9,400
| -66% | -$1.19M |
|
4133
Kimbell Royalty Partners
KRP
$1.52B
| $591K | ﹤0.01% |
34,808
-110,500
| -76% | -$1.89M |
|
4134
Invesco S&P 500 High Beta ETF
SPHB
$957M
| $589K | ﹤0.01% |
10,270
+10,032
| +4,215% | +$650K |
|
4135
ARK Genomic Revolution ETF
ARKG
$1.74B
| $588K | ﹤0.01% |
17,887
+2,633
| +17% | +$96.7K |
|
|
DCFC
4136
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
| $586K | ﹤0.01% |
918
+770
| +520% | +$965K |
|
4137
First Trust Water ETF
FIW
$1.92B
| $585K | ﹤0.01% |
8,156
+916
| +13% | +$71.4K |
|
|
LX
4138
LexinFintech Holdings
LX
$224M
| $585K | ﹤0.01% |
346,352
-1,515
| -0.4% | -$3.05K |
|
|
JNCE
4139
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $585K | ﹤0.01% |
250,067
-10,503
| -4% | -$37.2K |
|
|
CNCE
4140
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $585K | ﹤0.01% |
87,367
+41,018
| +88% | +$249K |
|
|
CTRA
4141
CALL
DELISTED
Coterra Energy
CTRA
| $582K | ﹤0.01% |
22,300
| – | – |
|
4142
Robinhood
HOOD
$85.9B
| $581K | ﹤0.01% |
57,476
+45,717
| +389% | +$440K |
|
4143
United States Natural Gas Fund
UNG
$487M
| $580K | ﹤0.01% |
6,197
-480
| -7% | -$52.6K |
|
4144
Yext
YEXT
$594M
| $577K | ﹤0.01% |
129,247
-310,551
| -71% | -$1.44M |
|
4145
Gorman-Rupp
GRC
$2.13B
| $575K | ﹤0.01% |
24,183
+2,061
| +9% | +$55.9K |
|
4146
Invesco Financial Preferred ETF
PGF
$668M
| $575K | ﹤0.01% |
38,221
-474
| -1% | -$7.5K |
|
4147
Immunocore
IMCR
$1.76B
| $573K | ﹤0.01% |
12,208
-898
| -7% | -$42.8K |
|
|
CCRN
4148
DELISTED
Cross Country Healthcare
CCRN
| $572K | ﹤0.01% |
20,168
-126,570
| -86% | -$3.25M |
|
4149
PUT
Yeti Holdings
YETI
$3.25B
| $570K | ﹤0.01% |
20,000
| – | – |
|
4150
Clover Health Investments
CLOV
$2.44B
| $569K | ﹤0.01% |
334,638
+11,882
| +4% | +$31.1K |
|
Similar funds
JP Morgan Chase's Q3 2022 Portfolio in Review
As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q3 2022 filing shows 557 new, 2,573 increased, 2,583 reduced and 516 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
- JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
- JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
- JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
- JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
- JP Morgan Chase opened 557 new positions and closed 516 in Q3 2022.
- JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.